Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia

One of the key features of acute myeloid leukemia (AML), a group of very aggressive myeloid malignancies, is their strikingly heterogenous outcomes. Accurate biomarkers are needed to improve prognostic assessment. Glutamate oxaloacetate transaminase 1 (GOT1) is essential for cell proliferation and a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Cheng, Zhiheng, Dai, Yifeng, Zeng, Tiansheng, Liu, Yan, Cui, Longzhen, Qian, Tingting, Si, Chaozeng, Huang, Wenhui, Pang, Ying, Ye, Xu, Shi, Jinlong, Fu, Lin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7105742/
https://ncbi.nlm.nih.gov/pubmed/32266153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00379
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia